Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application
Case Reports in Dermatological Medicine · 2011
DOI: 10.1155/2011/412684 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Dermatological Medicine, 2011. Verfasst von Natasha Atanaskova Mesinkovska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Cleveland Clinic, Cleveland, OH 44195, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%). Imiquimod has been associated with localized erythema, crusting, and scaling at the site of application. However, more severe generalized skin eruptions including erythema multiforme, psoriasis, and hyperpigmentation have been described. The newly approved imiquimod 3.75% cream is a presumably safer alternative due to its lower concentration. This paper describes the development of generalized acantholytic pityriasis rubra pilaris after the treatment of an actinic keratosis on the forehead with imiquimod 3.75% cream.
Autor:innen und Institutionen
- Department of Dermatology, Cleveland Clinic, Cleveland, OH 44195, USA.
Zitieren
APA
Atanaskova Mesinkovska, N., Dawes, D., Sood, A., & Bergfeld, W. (2011). Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application. Case Reports in Dermatological Medicine. https://doi.org/10.1155/2011/412684
Vancouver
Atanaskova Mesinkovska N, Dawes D, Sood A, Bergfeld W. Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application. Case Reports in Dermatological Medicine. 2011. doi:10.1155/2011/412684
BibTeX
@article{AtanaskovaMesinkovska2011,
author = {Atanaskova Mesinkovska, Natasha and Dawes, Danyelle and Sood, Apra and Bergfeld, Wilma},
title = {Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application},
journal = {Case Reports in Dermatological Medicine},
year = {2011},
doi = {10.1155/2011/412684}
}
EUVIMED